Patent US3608066A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3608066A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical preparation based on bacterial antigens

Assignee: EN NOM COLLECTIF SCIENCE UNION
•
Filing: 1969-06-16
•
Granted: 1971-09-21
•
Expires: 1989-06-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A pharmaceutical preparation for the treatment of infections of the respiratory tract, consisting of, in the desiccated and finely micronized state, lyophilized killed micro-organisms and their lyzates, selected from specific micro-organisms previously recognized to be responsible for such kind of infection, and also micro-organisms not previously recognized to be responsible for such kind of infection, and administered by inhalation in aerosol form.

Inventors

  • 👤 Paul-Robert Illartein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 20:55
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/007; A61K9/0073; A61K9/008; A61K39/00; A61K39/02

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 36 words
A pharmaceutical preparation as claimed in claim 1 which is micronized to a particle size of 2 to 5 so as to enable the antigens to penetrate deeply down to the level of the pulmonary alveoli.
Claim 2
Dependent Claim 15 words
A pharmaceutical preparation as claimed in claim 1, in aerosol form, including a propellant gas.
Claim 3
Dependent Claim 14 words
A pharmaceutical preparation as claimed in claim 7, wherein the propellant gas is dichlorodifluoromethane.
Claim 4
Dependent Claim 49 words
A pharmaceutical preparation as claimed in claim 1, which comprises different strains of the following micro-organisms: Escherichia coli, Pseudomonas aeruqinosa, Proteus vulgaris, Streptococcus faecalis, Streptococcus pyogenes, Staphylococcus aureus, Diplococcus pneumoniae, Neisseria catarrhalis, Hemophilus influenzae and Klebsiella pneumoniae, comprising on the order of 180 thousand million micro-organisms per unit package.
Claim 5
Dependent Claim 36 words
A pharmaceutical preparation as claimed in claim 9, comprising about 24 different strains of said micro-organisms. 7 A pharmaceutical preparation as claimed in claim 9 totaling on the order of 1,000 million micro-organisms per unit dose.
Claim 6
Dependent Claim 24 words
The preparation of claim 1 in an inhalation aerosol container provided with a dosing valve and charged with the said preparation of claim 1.
Claim 7
Dependent Claim 15 words
The preparation of claim 1 wherein the desiccated micro-organisms contain approximately 2 percent residual humidity.
Claim 8
Dependent Claim 54 words
Immunotherapeutic method of enhancing resistance and developing immunity in a living animal body against respiratory tract infection, which consists in administering to said living animal body in inhalation in aerosol form, three to 12 times a day, a pharmaceutical preparation as claimed in claim 1 containing on the order 1000 million micro-organisms per dose.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-09-20 1975-03-22 1975-09-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-09-20 1979-03-22 1979-09-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-09-20 1983-03-22 1983-09-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag